Marker Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Marker Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q1 2023.
  • Marker Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $5.33M, a 44.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $5.33M -$4.25M -44.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $5.48M -$4.35M -44.3% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 $5.63M -$4.45M -44.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $9.3M -$1.04M -10% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $9.57M -$1.02M -9.63% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $9.83M -$1.01M -9.35% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $10.1M -$974K -8.81% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $10.3M +$798K +8.36% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $10.6M +$10.2M +2497% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $10.8M +$10.4M +2282% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $11.1M +$10.6M +2104% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $9.54M +$8.99M +1643% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $408K -$185K -31.2% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $455K +$455K Dec 31, 2019 10-K 2021-03-09
Q3 2019 $502K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $547K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $592K Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $0 Dec 31, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.